Some cell types were not killed by treatment with PAL, suggesting it could be used as
a specific tumor therapy.
Not exact matches
Currently, many patients who acquire resistance to EGFR - targeted
therapy undergo a
tumor biopsy and are designated as either positive or negative for
specific secondary mutations.
Scientists now know that what matters most in determining the behavior of a particular cancer (and its response to
specific therapy) are the molecular pathways that drive malignant cell growth instead of where the
tumor begins in the body.
A randomized phase III trial finding that a new monoclonal antibody, elotuzumab, added to standard
therapy, extended the duration of remission for patients with relapsed multiple myeloma by about five months Findings from two phase III studies showing that children with Wilms
tumor who have a
specific chromosomal abnormality do better with a more intensive, augmented chemotherapy regimen
Hoping to cash in on personalized cancer
therapy, a new company called Foundation Medicine — founded in part by genome guru Eric Lander of the Broad Institute — plans to develop tests for genetic glitches in
tumors that make them vulnerable to
specific drugs, reports the United Kingdom's Times Online.
«Identifying targets essential to cell survival in
tumor suppressor genes has long been an investigational goal with the aim of offering cancer -
specific vulnerabilities for targeted
therapy,» said Ronald DePinho, M.D., professor of Cancer Biology, MD Anderson president, and senior author for the Nature paper.
Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a human trial in GBM using chimeric antigen receptor (CAR) T cell
therapy, through which patients» own T cells were engineered to track down and kill cancer cells that express a
tumor -
specific protein known as EGFRvIII.
This is important for the basic understanding of how these
tumors are formed and can contribute to the development of more efficient and
specific glioma
therapies.
In the featured article of The Journal of Nuclear Medicine's October issue, German researchers report on their recent clinical experience, which establishes a dosing regimen for actinium - 225 (225Ac)- labeled targeted alpha
therapy of patients with prostate
specific membrane antigen (PSMA)- positive
tumors.
Coupled with a review of these results by experts on a molecular
tumor board, the opportunity exists to identify novel
therapies that would target
specific abnormalities,» notes senior author of the work, Shridar Ganesan, MD, PhD, associate director for translational science at Rutgers Cancer Institute and associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School.
Comparing proteins within the microvesicles with the originating
tumors showed that the vesicles also accurately reveal the protein content of the
tumors, providing still more information about how
tumors might respond to
specific therapies, the researchers report.
This allows the circuit to target
tumors more accurately than existing
therapies, as it requires two cancer -
specific signals to be present before it will respond.
Therapies based on immune cells, which target particular
tumor molecules, are more
specific, but they are not effective against a variety of
tumors.
Physicians will now be able to categorize CNS
tumors more precisely into
specific risk groups and make
therapy decisions on this basis.
In their search for novel,
tumor -
specific therapies that could target multiple brain metastases without damaging adjacent tissues, the research team first developed a mouse model that more closely mimics what is seen in patients.
«RNAi
therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of
specific proteins involved in
tumor growth.»
Successful targets for
therapies are
specific to
tumor cells and not found on normal cells.
Investigating conventional MHC - restricted T cell responses
specific for
tumor - associated peptide antigens, and local immune contextures, in mediating cancer control in patients following neoadjuvant (per - surgery)
therapy.
Understanding these pathways helps identify therapeutic targets and is critical for the design of
tumor -
specific, less toxic
therapies.
Due to these physiopathological complexity and heterogeneously, one of the major requirements for a successful
therapy is the design of a multifunctional nanomedicines that is able to selectively attack
specific markers from
tumor and stroma cells.
Endogenous T cell
therapy utilizes naturally - occurring antigen -
specific T cells isolated from peripheral blood to treat solid
tumor malignancies.
These are more
specific therapies such as monoclonal antibodies and cancer vaccines, which target
specific tumor antigens.
But other antigens, unless they are truly
tumor -
specific, may not be suitable targets for this form of
therapy.
Since
therapy is increasingly guided by the genetic aberrations in
tumors, Herlyn and his colleagues are developing combinations of compounds that take into account the genetic signature of
tumors, with the
specific goal of individualized cancer
therapy.
University of Texas M.D. Anderson Cancer Center
Tumor -
specific alloantigen - anergic donor - derived T - cell
therapy after hematopoietic stem - cell transplantation
2004: IMRT (Intensity Modulated Radiation
Therapy) Program began to deliver high - precision radiation that conforms to the three dimensional shapes of
tumors and delivers higher and well defined doses of radiation to
tumors, and even
specific areas within
tumors, while minimizing radiation to surrounding normal tissue.
In the next several years, when the laboratory process for recreating micro
tumors is fast and reliable, Dr. Simeone expects to offer a Phase 1 clinical trial to design tailored single and combination
therapies, as well as experimental agents targeting
specific mutations.
The company's lead candidate, GLN - 1001, is a first - in - class, orally available oncolytic small molecule, currently being developed as a potentially disease modifying
therapy for glioblastoma by targeting
specific vulnerabilities in
tumor cells.
Identifying
tumor -
specific biomarkers to optimize selection of targeted
therapies and to better predict response to
therapy
11/19/2007 New Technology to Treat Breast Cancer Shows Promise in Early Application Physicians at the Rebecca and John Moores UCSD Cancer Center will present the initial outcomes of their use of a new device that delivers radiation
therapy to a
specific tumor site at the annual meeting of the Radiological Society of North America (R...
Patients whose melanoma
tumors do not have BRAF alterations will have other
specific genetic alterations identified and these changes will be matched to an appropriate
therapy that directly targets those alterations.
By exploiting these differences, scientists have developed
therapies that target
specific tumor types, and these targeted
therapies have proven useful against most breast cancers.
National Cancer Institute and ECOG - ACRIN announce the July 2015 opening of the NCI - MATCH / EAY131 trial, a multi-arm phase II precision medicine study that seeks to determine whether targeted
therapies for people whose
tumors have
specific gene mutations will be effective regardless of cancer type.
Provenge and other therapeutic vaccines involve personalized
therapy that targets the patient's
specific tumor.
Primary treatment for
specific tumor types Indications for the use of external beam radiation
therapy for the primary treatment of
tumors has expanded significantly with the emergence of SRS for pets.
Indications for radiation
therapy (RT) include the primary treatment of
specific tumor types, such as nasal
tumors and brain
tumors, adjuvant treatment of incompletely excised
tumors, and palliation to improve quality of life for patients with non-resectable or advanced cancers.
The scientists are also continuing to investigate mutations that occur in the
tumors themselves (somatic mutations) and are profiling the susceptibility of
specific tumor types to various chemotherapy compounds, which may lead to improved
therapy options.
Re-directed Autologous T cell
Therapy for drug resistant or refractory CD20 + B cell lymphoma Overview: In this approach, immune cells (known as T cells) are taken from the peripheral blood, genetically modified in the laboratory to express a receptor that recognizes B cells, and then expanded to produce large numbers of
tumor specific T cells outside -LSB-...]